Literature DB >> 12560276

Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement.

R van Leeuwen1, J R Vingerling, A Hofman, P T V M de Jong, B H Ch Stricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12560276      PMCID： PMC140763          DOI： 10.1136/bmj.326.7383.255

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

Authors:  B A in t' Veld; A Ruitenberg; A Hofman; L J Launer; C M van Duijn; T Stijnen; M M Breteler; B H Stricker
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

2.  Risk of macular degeneration in users of statins: cross sectional study.

Authors:  N F Hall; C R Gale; H Syddall; D I Phillips; C N Martyn
Journal:  BMJ       Date:  2001-08-18

3.  Extracts from "clinical evidence": age related macular degeneration.

Authors:  J J Arnold; S H Sarks
Journal:  BMJ       Date:  2000-09-23

4.  Cholesterol-lowering medications reduce the risk of age-related maculopathy progression.

Authors:  C A McCarty; B N Mukesh; R H Guymer; P N Baird; H R Taylor
Journal:  Med J Aust       Date:  2001-09-17       Impact factor: 7.738

Review 5.  An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

Authors:  A C Bird; N M Bressler; S B Bressler; I H Chisholm; G Coscas; M D Davis; P T de Jong; C C Klaver; B E Klein; R Klein
Journal:  Surv Ophthalmol       Date:  1995 Mar-Apr       Impact factor: 6.048
  5 in total
  32 in total

1.  Update of the vascular model of AMD.

Authors:  E Friedman
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

Review 2.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

3.  Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration.

Authors:  J L Duncan
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 4.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

Review 5.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

Review 6.  Statins for age-related macular degeneration.

Authors:  Peter Gehlbach; Tianjing Li; Elham Hatef
Journal:  Cochrane Database Syst Rev       Date:  2015-02-11

7.  Statin use and the five-year incidence and progression of age-related macular degeneration.

Authors:  Ronald Klein; Michael D Knudtson; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-05-02       Impact factor: 5.258

8.  Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach.

Authors:  Alexandra C Silveira; Margaux A Morrison; Fei Ji; Haiyan Xu; James B Reinecke; Scott M Adams; Trevor M Arneberg; Maria Janssian; Joo-Eun Lee; Yang Yuan; Debra A Schaumberg; Maria G Kotoula; Evangeline E Tsironi; Aristoteles N Tsiloulis; Dimitrios Z Chatzoulis; Joan W Miller; Ivana K Kim; Gregory S Hageman; Lindsay A Farrer; Neena B Haider; Margaret M DeAngelis
Journal:  Vision Res       Date:  2009-09-26       Impact factor: 1.886

9.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

10.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.